HomeCompareHNGZY vs NOBL

HNGZY vs NOBL: Dividend Comparison 2026

HNGZY yields 0.72% · NOBL yields 2.14%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 HNGZY wins by $1.65M in total portfolio value· pulled ahead in Year 3
10 years
HNGZY
HNGZY
● Live price
0.72%
Share price
$4.00
Annual div
$0.03
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$1.68M
Annual income
$1,324,338.59
Full HNGZY calculator →
NOBL
NOBL
● Live price
2.14%
Share price
$106.01
Annual div
$2.27
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$22.8K
Annual income
$246.19
Full NOBL calculator →

Portfolio growth — HNGZY vs NOBL

📍 HNGZY pulled ahead of the other in Year 3

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodHNGZYNOBL
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, HNGZY + NOBL cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
HNGZY pays
NOBL pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

HNGZY
Annual income on $10K today (after 15% tax)
$61.54/yr
After 10yr DRIP, annual income (after tax)
$1,125,687.80/yr
NOBL
Annual income on $10K today (after 15% tax)
$182.19/yr
After 10yr DRIP, annual income (after tax)
$209.26/yr
At 15% tax rate, HNGZY beats the other by $1,125,478.54/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of HNGZY + NOBL for your $10,000?

HNGZY: 50%NOBL: 50%
100% NOBL50/50100% HNGZY
Portfolio after 10yr
$849.3K
Annual income
$662,292.38/yr
Blended yield
77.98%
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

HNGZY buys
0
NOBL buys
0
No recent congressional trades found for HNGZY or NOBL in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricHNGZYNOBL
Forward yield0.72%2.14%
Annual dividend / share$0.03$2.27
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR100%0%
Portfolio after 10y$1.68M$22.8K
Annual income after 10y$1,324,338.59$246.19
Total dividends collected$1.62M$2.3K
Payment frequencyquarterlyquarterly
SectorStockETF

Year-by-year: HNGZY vs NOBL ($10,000, DRIP)

YearHNGZY PortfolioHNGZY Income/yrNOBL PortfolioNOBL Income/yrGap
1$10,845$144.81$10,914$214.34$69.00NOBL
2$11,897$293.53$11,897$218.63$0.00NOBL
3← crossover$13,332$601.91$12,952$222.72+$380.00HNGZY
4$15,526$1,260.74$14,086$226.62+$1.4KHNGZY
5$19,357$2,744.31$15,302$230.33+$4.1KHNGZY
6$27,108$6,395.29$16,607$233.85+$10.5KHNGZY
7$45,745$16,739.89$18,007$237.18+$27.7KHNGZY
8$101,749$52,802.12$19,508$240.35+$82.2KHNGZY
9$328,397$219,525.46$21,116$243.35+$307.3KHNGZY
10$1,675,724$1,324,338.59$22,841$246.19+$1.65MHNGZY

HNGZY vs NOBL: Complete Analysis 2026

HNGZYStock

Hangzhou Tigermed Consulting Co., Ltd. provides contract research organization services in the People's Republic of China and internationally. It operates in Clinical Trial Solutions, and Clinical-related and Laboratory Services segments. The company offers regulatory submission and approval, medical translation, and good manufacturing practice (GMP) consulting services; and clinical services in the areas of medical science, early clinical and late phase development, medical monitoring, project management, patient recruitment, and quality management system. It also provides biometrics services comprising data management, biostatistics, and statistical programming; and integrated technology services, such as site management, pharmacovigilance, third party audit and training, medical imaging, clinical trial system solution, central laboratory, pre-clinical, and research hospital. Further, the company offers medical device/ in vitro diagnostics (IVD) services comprising medical device testing, regulatory submission, clinical evaluation and trials, GMP certificate, EU MDR and IVDR preparation, and value-added services; and post-marketing study, real world evidence, and vaccine clinical trial services. Hangzhou Tigermed Consulting Co., Ltd. was incorporated in 2004 and is headquartered in Hangzhou, the People's Republic of China.

Full HNGZY Calculator →

NOBLETF

The fund will invest at least 80% of its total assets in component securities of the index. The index contains a minimum of 40 stocks, which are equally weighted, and no single sector is allowed to comprise more than 30% of the index weight. It seeks to remain fully invested at all times in securities and/or financial instruments that, in combination, provide exposure to the returns of the index without regard to market conditions, trends or direction.

Full NOBL Calculator →
📬

Get this HNGZY vs NOBL comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

HNGZY vs SCHDHNGZY vs JEPIHNGZY vs OHNGZY vs KOHNGZY vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.